We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$194M
Cap. Flow
+$40.5M
Cap. Flow %
2.24%
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74

Top Buys

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$32.5M
2
AMAT icon
Applied Materials
AMAT
+$26.5M
3
AAPL icon
Apple
AAPL
+$13.7M
4
MSFT icon
Microsoft
MSFT
+$11.9M
5
NVDA icon
NVIDIA
NVDA
+$9.49M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$28.3M
2
BEKE icon
KE Holdings
BEKE
+$13.2M
3
TSM icon
TSMC
TSM
+$13.2M
4
ASX icon
ASE Group
ASX
+$7.59M
5
IQ icon
iQIYI
IQ
+$6.13M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.73%
2 Technology 31.74%
3 Communication Services 9.52%
4 Healthcare 5.08%
5 Financials 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRSK icon
201
Verisk Analytics
VRSK
$25B
$387K 0.02%
1,434
+21
+1% +$5.14K
GE icon
202
GE Aerospace
GE
$355B
$377K 0.02%
2,369
-7,006
-75% -$1.12M
ODFL icon
203
Old Dominion Freight Line
ODFL
$41.2B
$374K 0.02%
2,120
+36
+2% +$6.79K
KHC icon
204
Kraft Heinz
KHC
$30.5B
$373K 0.02%
11,586
+233
+2% +$8.3K
TTD icon
205
Trade Desk
TTD
$6.38B
$372K 0.02%
3,805
+82
+2% +$7.4K
EA
206
DELISTED
Electronic Arts
EA
$369K 0.02%
2,645
+41
+2% +$5.4K
ELV icon
207
Elevance Health
ELV
$85.5B
$367K 0.02%
678
-35
-5% -$18.5K
TGTX icon
208
TG Therapeutics
TGTX
$8.26B
$364K 0.02%
20,465
-5,361
-21% -$85.5K
FAST icon
209
Fastenal
FAST
$57.1B
$361K 0.02%
11,478
+214
+2% +$7.22K
SWTX
210
DELISTED
SpringWorks Therapeutics
SWTX
$357K 0.02%
9,467
+981
+12% +$41.3K
DASH icon
211
DoorDash
DASH
$103B
$355K 0.02%
3,263
+111
+4% +$13.4K
BKR icon
212
Baker Hughes
BKR
$62B
$353K 0.02%
10,045
+159
+2% +$5.21K
HPQ icon
213
HP
HPQ
$27.5B
$351K 0.02%
10,024
+2,812
+39% +$89.2K
EXC icon
214
Exelon
EXC
$45.3B
$347K 0.02%
10,018
+187
+2% +$6.9K
GLW icon
215
Corning
GLW
$128B
$346K 0.02%
8,910
+2,454
+38% +$85.7K
SYK icon
216
Stryker
SYK
$127B
$344K 0.02%
1,011
-3
-0.3% -$1.02K
DDOG icon
217
Datadog
DDOG
$85.1B
$342K 0.02%
2,637
-1,803
-41% -$218K
BSX icon
218
Boston Scientific
BSX
$67.9B
$340K 0.02%
4,410
-413
-9% -$30.2K
NEE icon
219
NextEra Energy
NEE
$171B
$329K 0.02%
+4,653
New +$330K
IOVA icon
220
Iovance Biotherapeutics
IOVA
$3.63B
$328K 0.02%
40,912
+13,310
+48% +$143K
MDT icon
221
Medtronic
MDT
$117B
$326K 0.02%
4,148
+24
+0.6% +$1.97K
HPE icon
222
Hewlett Packard
HPE
$69.3B
$319K 0.02%
15,078
+4,502
+43% +$83K
WB icon
223
Weibo
WB
$1.72B
$319K 0.02%
41,516
RARE icon
224
Ultragenyx Pharmaceutical
RARE
$2.52B
$315K 0.02%
7,662
-915
-11% -$39.1K
CI icon
225
Cigna
CI
$73.7B
$314K 0.02%
950
-9
-0.9% -$3.1K

Similar funds

E Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, E Fund Management held 392 positions worth $1.81B, up 12% from $1.61B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

E Fund Management's Q2 2024 filing shows 24 new, 176 increased, 102 reduced and 74 closed positions. Its largest new stake was Futu Holdings: 480,000 shares worth $31.5M. The largest sale was Advanced Micro Devices, an estimated $28.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q2 2024 buy was Futu Holdings: 480,000 shares worth $31.5M.
  • E Fund Management added most to Applied Materials in Q2 2024, an estimated $26.5M increase.
  • E Fund Management's biggest Q2 2024 reduction was Advanced Micro Devices, cutting an estimated $28.3M.
  • E Fund Management fully exited Yum China in Q2 2024, selling an estimated $5.17M.
  • E Fund Management's ten largest holdings make up 64% of its $1.81B portfolio in Q2 2024.
  • E Fund Management opened 24 new positions and closed 74 in Q2 2024.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.81B.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.